Medigen Biotechnology Corp. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 1,385.01 million compared to TWD 154.13 million a year ago. Net income was TWD 63.61 million compared to net loss of TWD 110.63 million a year ago. Basic earnings per share was TWD 0.46 compared to basic loss per share of TWD 0.79 a year ago. For the nine months, sales was TWD 1,745.53 million compared to TWD 425.49 million a year ago. Net loss was TWD 129.74 million compared to TWD 271.39 million a year ago. Basic loss per share was TWD 0.93 compared to TWD 1.95 a year ago.